Table 2.
Life expectancy (additional years of life) among HIV-infected people enrolled in care (received antiretroviral therapy), by age group
| 15–19 years | 20–24 years | 25–29 years | 30–34 years | 35–39 years | 40–44 years | 45–49 years | 50–54 years | 55–59 years | 60+ years | |
| Total number | 48 | 87 | 326 | 718 | 773 | 620 | 339 | 159 | 62 | 59 |
| Total death | 2 | 12 | 37 | 69 | 81 | 72 | 38 | 20 | 5 | 8 |
| Overall | 10.2 (7.6 to 14.1) |
7.1 (5.5 to 10.4) |
9.0 (7.6 to 10.4) |
8.7 (8.4 to 10.4) |
8.2 (7.8 to 9.8) |
7.5 (7.2 to 9.4) |
7.3 (6.7 to 9.5) |
7.0 (5.8 to 9.0) |
6.6 (5.3 to 8.3) |
3.8 (3.8 to 3.8) |
| Gender | ||||||||||
| Male | 8.0 (3.8 to 12.2) |
6.4 (3.3 to 9.5) |
6.7 (5.1 to 8.3) |
7.6 (6.5 to 8.7) |
6.9 (5.9 to 7.9) |
6.9 (5.8 to 8.1) |
7.0 (5.4 to 8.5) |
7.0 (5.0 to 8.9) |
6.5 (4.9 to 8.2) |
3.3 (3.3 to 3.3) |
| Female | 12.7 (8.9 to 16.5) |
7.7 (3.9 to 11.5) |
10.5 (8.0 to 12.9) |
10.7 (8.8 to 12.7) |
10.7 (8.6 to 12.8) |
9.1 (6.8 to 11.3) |
8.6 (5.9 to 11.3) |
6.6 (3.7 to 9.6) |
6.7 (3.3 to 10.1) |
5.0 (5.0 to 5.0) |
| Ethnicity | ||||||||||
| Non-indigenous | 10.7 (5.6 to 15.8) |
7.9 (3.7 to 12.1) |
9.0 (6.8 to 11.1) |
8.9 (7.5 to 10.4) |
8.3 (6.8 to 9.7) |
7.4 (5.9 to 9.0) |
7.1 (5.2 to 9.1) |
7.3 (4.9 to 9.7) |
6.4 (4.3 to 8.6) |
3.8 (3.8 to 3.8) |
| Indigenous | 9.4 (5.7 to 13.2) |
6.2 (3.5 to 8.9) |
7.4 (5.7 to 9.1) |
8.3 (7.1 to 9.5) |
7.7 (6.5 to 9.0) |
7.5 (6.1 to 9.0) |
7.6 (5.8 to 9.5) |
6.5 (4.4 to 8.7) |
6.8 (4.6 to 9.0) |
3.7 (3.7 to 3.7) |
| CD4 cell count (cells/cm3) | ||||||||||
| ≤50 | 2.8 (0.8 to 4.8) |
1.3 (1.3 to 1.3) |
3.7 (2.3 to 5.1) |
4.9 (3.4 to 6.3) |
5.9 (4.3 to 7.5) |
6.0 (4.7 to 7.4) |
3.6 (2.6 to 4.6) |
2.4 (2.4 to 2.4) |
2.5 (2.4 to 8.4) |
2.4 (2.4 to 2.4) |
| 51–100 | 3.9 (−0.6 to 8.4) |
3.6 (0.8 to 6.4) |
5.2 (2.9 to 7.5) |
6.4 (4.9 to 7.8) |
4.8 (3.7 to 5.8) |
3.5 (2.5 to 4.5) |
6.4 (3.9 to 8.8) |
5.6 (2.6 to 8.5) |
4.7 (1.6 to 7.8) |
3.3 (3.3 to 3.3) |
| 101–200 | 9.4 (6.2 to 12.6) |
4.4 (1.3 to 7.6) |
9.1 (6.4 to 11.7) |
8.9 (6.9 to 10.8) |
9.2 (7.2 to 11.2) |
9.9 (7.5 to 12.3) |
9.2 (6.4 to 12.1) |
9.7 (6.5 to 12.9) |
8.7 (8.7 to 8.7) |
3.7 (3.7 to 3.7) |
| >200 | 27.4 (22.3 to 32.6) |
22.4 (17.3 to 27.6) |
17.4 (12.3 to 22.6) |
18.1 (13.9 to 22.2) |
15.8 (11.6 to 20.1) |
15.8 (11.2 to 20.3) |
13.9 (9.1 to 18.7) |
13.1 (9.8 to 16.5) |
10.0 (10.0 to 10.0) |
5.0 (5.0 to 5.0) |
| WHO clinical stage | ||||||||||
| Stage I | 23.1 (16.6 to 29.7) |
18.1 (11.6 to 24.7) |
16.3 (12.5 to 20.1) |
13.9 (10.6 to 17.1) |
13.0 (9.6 to 16.4) |
11.5 (7.8 to 15.2) |
12.1 (7.8 to 16.3) |
12.0 (8.4 to 15.6) |
10.0 (10.0 to 10.0) |
5.0 (5.0 to 5.0) |
| Stage II | 22.5 (14.6 to 30.4) |
17.5 (9.6 to 25.4) |
16.3 (11.1 to 21.5) |
18.5 (14.9 to 22.1) |
15.2 (11.7 to 18.8) |
14.0 (10.2 to 17.8) |
12.6 (8.5 to 16.7) |
12.1 (8.6 to 15.6) |
10.0 (10.0 to 10.0) |
5.0 (5.0 to 5.0) |
| Stage III | 4.6 (1.5 to 7.6) |
3.1 (1.3 to 4.9) |
7.1 (4.8 to 9.3) |
8.4 (6.7 to 10.1) |
7.9 (6.3 to 9.6) |
7.7 (5.9 to 9.5) |
8.4 (5.9 to 10.8) |
7.2 (4.2 to 10.2) |
8.0 (5.8 to 10.1) |
4.2 (4.2 to 4.2) |
| Stage IV | 6.2 (6.2 to 6.2) |
1.2 (1.2 to 1.2) |
2.6 (2.3 to 2.9) |
2.4 (2.4 to 2.4) |
2.9 (2.4 to 3.4) |
3.1 (2.4 to 3.7) |
2.7 (2.2 to 3.2) |
2.4 (2.4 to 2.4) |
1.7 (1.7 to 1.7) |
2.1 (2.1 to 2.1) |
Numbers inside parenthesis are 95% CI. Life expectancy was defined as the average number of additional years that will be lived by a person after that age.